The First Relief® percutaneous electrical nerve field stimulator (PENS) is designed to administer auricular neurostimulation treatment over 168 hours. Stimulation is performed by sending electrical pulses emitted through needles strategically positioned in the ear. The ear provides numerous points for stimulation within a small area.
First Relief® neurostimulation therapy has been cleared by the FDA to treat neuropathic pain in Type II diabetics. First Relief® therapy allows neurostimulation over a period over 16 weeks using 8 treatments while offering the patient a high degree of comfort and mobility. Use of the First Relief® therapy allows for a minimized use of opioid agonist treatment and in some cases may eliminate it.
First Relief® devices come packaged 10 to a box.